Kronox Lab Q2FY26: PAT Rs 6.28 cr on Rs 24.29 cr revenue

Results View source PDF Explain this filing

KRONOX · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.9%Reaction day

₹150.00

prior close

₹149.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.9%-2.9% vs market

Specialty Chemicals peers, median of 85sector+0.7%-2.7% vs sector

On the reaction day the stock moved 2.9 pts less than Nifty Microcap 250 and 2.7 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.0

10m

-1.3

15m

-1.1

30m

-1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.9+0.9-2.9+0.7-2.7

Next day

-0.6+0.8-1.4+0.4-1.0

-0.7+0.7-1.4+0.5-1.1

-1.3+1.3-2.6-0.1-1.2

-2.6+0.5-3.1-0.8-1.8

-3.6+0.4-3.9-1.8-1.7

-5.2-1.5-3.7-2.3-2.9

15d

-8.6-2.4-6.2-4.1-4.6

-4.0-4.4+0.4-5.2+1.2

-12.2-7.2-5.0-8.9-3.3

-15.9-5.0-10.9-8.6-7.3

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 85Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Kronox Lab Sciences reported Q2FY26 standalone revenue of Rs 24.29 cr (vs Rs 24.86 cr YoY) and PAT of Rs 6.28 cr (vs Rs 5.54 cr). For H1FY26, revenue was Rs 49.82 cr against Rs 50.05 cr, while PAT rose to Rs 13.07 cr from Rs 12.62 cr. EPS stood at Rs 3.54 for H1. Auditor Mahesh Udhwani and Associates issued an unqualified review. Final dividend of 5 percent for FY25 was paid in September 2025.

Likely market impact

Marginal revenue dip with modest PAT growth; clean audit report and steady margins signal operational stability for shareholders.